Related Experiment Video
Updated: Aug 24, 2025
12:43
Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
12.4K
Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restriction
Alina Russ1, Sabine Wittmann1, Yuta Tsukamoto2
1Institute of Clinical and Molecular Virology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
EMBO Reports
|October 26, 2022
Summary
SARS-CoV-2
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Cellular methyltransferases cap mRNA 5' ends for translation and immune evasion.
- Coronaviruses utilize viral 2'-O-methyltransferases to protect their RNA from host defenses.
Purpose of the Study:
- To investigate the role of SARS-CoV-2's 2'-O-methyltransferase (Nsp16) in viral replication and immunogenicity.
- To assess the potential of Nsp16 as a target for developing attenuated and immunogenic SARS-CoV-2 strains.
Main Methods:
- Generation of recombinant SARS-CoV-2 with catalytically inactive Nsp16 (Nsp16mut).
- Analysis of viral replication and immunogenicity in human lung epithelial cells.
- Investigation of the roles of MDA5, type I interferon (IFN), and IFIT1 in the Nsp16mut response.
Main Results:
- SARS-CoV-2 Nsp16mut showed slightly attenuated replication but significantly enhanced immunogenicity, with increased type I IFN release.
- The heightened immunogenicity of Nsp16mut was dependent on the RNA sensor MDA5.
- Nsp16mut was sensitive to type I IFN treatment, with IFIT1 mediating the antiviral effect.
Conclusions:
- SARS-CoV-2 Nsp16 plays a dual role in evading MDA5 recognition and interferon-induced antiviral responses.
- Nsp16 is a promising target for creating attenuated, highly immunogenic SARS-CoV-2 strains and for therapeutic intervention.
